Significantly increased risk for tardive dyskinesia seen with doses >75 mg/day at last prescription and as maximum dose ...

HealthDay News — Antipsychotics at doses >75 mg ... (TD), according to a study recently published in the Journal of Clinical Psychopharmacology. Maki Gouda, from the Mitsubishi Tanabe Pharma ...

published in the Journal of the American Geriatrics Society. “Antipsychotics are commonly used off-label as first-line agents for pharmacological treatment of behavioral and psychological ...

Examining the difference between the terms "response" and "recovery" reflects the enormous difference in the worlds of scientific literature and the clinical practice of psychopharmacology.

clinical, imaging and psychopharmacology levels. Learn more about the journal here. Ranked in the top 10 Psychiatry journals, we aim to elucidate the biological mechanisms underlying psychiatric ...

Antipsychotics at doses >75 mg/day are associated with an increased risk for tardive dyskinesia (TD), according to ...

Antipsychotics at doses >75 mg/day are associated with an increased risk for tardive dyskinesia (TD), according to a study published in the Journal of Clinical Psychopharmacology. Maki Gouda ...